V-Square Quantitative Management’s Biogen BIIB Stock Holding History

V-Square Quantitative Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$940K	Sell	4,349 -9	-0.2%	-$1.72K	0.09%	198
2026 Q1	$799K	Buy	4,358 +238	+6%	+$43.9K	0.08%	204
2025 Q4	$725K	Buy	+4,120	New	+$673K	0.08%	222
2025 Q3	–	Sell	-4,679	Closed	-$588K	–	203
2025 Q2	$588K	Buy	4,679 +470	+11%	+$58.6K	0.08%	264
2025 Q1	$576K	Buy	4,209 +194	+5%	+$27.7K	0.08%	264
2024 Q4	$614K	Buy	4,015 +180	+5%	+$30.4K	0.09%	254
2024 Q3	$743K	Buy	3,835 +261	+7%	+$54.6K	0.11%	195
2024 Q2	$829K	Buy	3,574 +329	+10%	+$71.5K	0.13%	141
2024 Q1	$700K	Buy	3,245 +584	+22%	+$137K	0.1%	180
2023 Q4	$689K	Buy	2,661 +639	+32%	+$157K	0.12%	138
2023 Q3	$520K	Buy	2,022 +816	+68%	+$218K	0.23%	82
2023 Q2	$344K	Buy	1,206 +21	+2%	+$6.25K	0.25%	77
2023 Q1	$329K	Buy	+1,185	New	+$328K	0.3%	83

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

V-Square Quantitative Management's BIIB Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Biogen (BIIB) stake by 0.21% in Q2 2026, selling an estimated $1.72K and leaving 4,349 shares worth $940K. The position accounts for 0.09% of the portfolio, ranked #198.

V-Square Quantitative Management first reported a position in BIIB in Q1 2023 and has held it in 13 quarters since. 373 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

V-Square Quantitative Management held 4,349 shares of Biogen worth $940K as of Q2 2026.
V-Square Quantitative Management sold 9 Biogen shares in Q2 2026, an estimated $1.72K.
Biogen made up 0.09% of V-Square Quantitative Management's portfolio in Q2 2026, its #198 holding.
V-Square Quantitative Management first reported a position in Biogen in Q1 2023 and has held it in 13 quarters since.
373 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.